Shaanxi Meibang Pharmaceutical (605033)
Search documents
美邦股份(605033) - 美邦股份2026年第一次临时股东会法律意见书
2026-01-15 09:30
国浩律师(上海)事务所 关 于 陕西美邦药业集团股份有限公司 2026 年第一次临时股东会 的 法律意见书 上海市静安区山西北路 99 号苏河湾中心 25-28 楼 邮编:200085 25-28/F, Suhe Centre, 99 North Shanxi Road, Jing'an District, Shanghai, China 电话/Tel: +86 21 5234 1668 传真/Fax: +86 21 5234 1670 网址/Website: http://www.grandall.com.cn 2026 年 1 月 国浩律师(上海)事务所 股东会法律意见书 国浩律师(上海)事务所 关于陕西美邦药业集团股份有限公司 2026 年第一次临时股东会的法律意见书 致:陕西美邦药业集团股份有限公司 一、本次股东会的召集、召开程序 1. 经核查,公司 2026 年第一次临时股东会由公司董事会召集。公司董事会 已于本次会议召开 15 日以前(即 2025 年 12 月 26 日)在上海证券交易所网站上 发布《陕西美邦药业集团股份有限公司关于召开 2026 年第一次临时股东会的通 知》。 公司发布的公告载 ...
美邦股份:公司目前生产经营正常
Zheng Quan Ri Bao Zhi Sheng· 2026-01-12 14:17
Group 1 - The core viewpoint of the article is that the company's stock price in the secondary market is influenced by multiple factors, including policy environment, market environment, and investor risk appetite [1] - The company stated that its production and operations are currently normal [1] - The company will strictly adhere to information disclosure regulations regarding its specific performance situation [1]
美邦股份(605033) - 陕西美邦药业集团股份有限公司2026年第一次临时股东会会议资料
2026-01-09 09:30
2026 年第一次临时股东会会议资料 陕西美邦药业集团股份有限公司 二〇二六年第一次临时股东会 会议资料 二〇二六年一月 2026 年第一次临时股东会会议资料 会议须知 为确保陕西美邦药业集团股份有限公司(以下简称"本公司"或"公司") 股东在本公司 2026 年第一次临时股东会(以下简称"本次会议")依法行使权 利,保证会议秩序和议事效率,相关事项如下: 一、公司根据《中华人民共和国公司法》《中华人民共和国证券法》《陕西 美邦药业集团股份有限公司章程》(以下简称"《公司章程》")及《陕西美邦 药业集团股份有限公司股东会议事规则》规定,认真做好本次会议的各项工作。 二、公司董事会在本次会议过程中,应当认真履行法定职责,维护股东合法 权益。 三、公司股东出席本次会议,依法享有《公司章程》规定的各项权利,并认 真履行法定义务,不得侵犯其他股东的合法权益,不得扰乱本次会议的正常秩序。 四、本次会议议案的表决采取现场记名投票与网络投票相结合的方式投票表 决。本次会议议案全部是采用非累积投票制进行投票:股东以其持有的有表决权 的股份数额行使表决权,每一股份享有一票表决权。股东在投票表决时,应在表 决票中每项议案下设的" ...
农化制品板块12月29日跌1.48%,润丰股份领跌,主力资金净流出6.37亿元
Zheng Xing Xing Ye Ri Bao· 2025-12-29 08:58
Market Overview - The agricultural chemical sector experienced a decline of 1.48% on December 29, with Runfeng Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Stock Performance - Notable gainers in the agricultural chemical sector included: - Beisimei (300796) with a closing price of 8.76, up 1.39% on a trading volume of 54,300 shares and a turnover of 47.32 million yuan [1] - Nongxin Technology (001231) at 22.72, up 1.38% with a trading volume of 25,600 shares and a turnover of 57.69 million yuan [1] - Baiao Chemical (603360) at 31.68, up 1.38% with a trading volume of 120,500 shares and a turnover of 381 million yuan [1] - Conversely, significant decliners included: - Runfeng Co., Ltd. (301035) at 66.10, down 5.58% with a trading volume of 34,100 shares and a turnover of 228 million yuan [2] - Yanhai Co., Ltd. (000792) at 27.69, down 4.48% with a trading volume of 1,063,600 shares and a turnover of 2.994 billion yuan [2] - Zhejiang Agricultural Co., Ltd. (002758) at 9.83, down 3.91% with a trading volume of 170,200 shares [2] Capital Flow - The agricultural chemical sector saw a net outflow of 637 million yuan from institutional investors, while retail investors contributed a net inflow of 407 million yuan [2] - Key stocks with notable capital flows included: - Yuntianhua (600096) with a net inflow of 12.8 million yuan from institutional investors [3] - Baiao Chemical (603360) with a net inflow of 18.96 million yuan from institutional investors [3] - Runfeng Co., Ltd. (301035) had a net outflow of 30.6 million yuan from institutional investors but a net inflow of 20.74 million yuan from retail investors [3]
美邦股份:第三届董事会第十次会议决议公告
Zheng Quan Ri Bao· 2025-12-25 13:20
证券日报网讯 12月25日,美邦股份发布公告称,美邦股份第三届董事会第十次会议审议通过《关于募 投项目结项并将节余募集资金永久补充流动资金的议案》等多项议案。 (文章来源:证券日报) ...
美邦股份:2026年1月15日召开2026年第一次临时股东会
Zheng Quan Ri Bao· 2025-12-25 12:14
Group 1 - The company, Meibang Co., announced that it will hold its first extraordinary general meeting of shareholders for 2026 on January 15, 2026 [2]
12月25日晚间重要公告一览
Xi Niu Cai Jing· 2025-12-25 10:18
Group 1 - Guangdong Construction signed an EPC contract worth 416 million yuan, with a total construction area of 99,595.6 square meters and a construction period of 640 calendar days [1] - Hekang New Energy's subsidiary received a government subsidy of 6 million yuan, accounting for 58.27% of the company's latest audited net profit attributable to shareholders [2] - Jinbei Automotive signed a memorandum of understanding with E-Works to establish a research and development center for electric light commercial vehicles [3] Group 2 - Hongsheng Huayuan is expected to win approximately 569 million yuan in procurement projects from the State Grid, which represents about 5.61% of the company's projected revenue for 2024 [4] - Zhongding Co. plans to establish a joint venture for humanoid robot manufacturing with a registered capital of 50 million yuan [5] - Kede CNC's new factory in Shenyang is expected to achieve an annual production capacity of about 60 units [6] Group 3 - Hongbo Pharmaceutical's share transfer price is set at 25.27 yuan per share [7] - ST Jinglan plans to sign a letter of intent for the acquisition of Xinlian Environmental Technology Co., enhancing its core technology competitiveness [8][9] - Hato Co. announced the resignation of its general manager due to job relocation [10] Group 4 - Meibang Co. plans to apply for a new bank credit line of up to 160 million yuan [11] - Southern Media's general manager resigned due to job relocation [12] - Dalian Electric Porcelain's subsidiary is expected to win procurement projects from the State Grid worth approximately 70.7 million yuan [13] Group 5 - Sinopharm Modern's subsidiary received a drug registration certificate for a new medication [14] - ST Meigu plans to implement a capital reserve transfer to increase share capital, leading to a one-day stock suspension [15] - Ruisheng Intelligent confirmed a transaction of 152 million yuan for domestic computing equipment procurement [16] Group 6 - Jinguang Electric won three procurement packages from the State Grid, totaling 37.43 million yuan [17] - Guangju Energy increased its stake in Mawan Power to 14.42% by acquiring an 8% share for 680 million yuan [18][19] - ST Lingda announced a stock suspension due to capital reserve transfer related to its restructuring plan [20] Group 7 - Suli Co. plans to increase its investment in Suli Ningxia by 76.63 million yuan [21] - Dalian Shengya's subsidiary plans to reduce its registered capital by 32.37 million yuan [22] - Yinxin Technology received a cash dividend of 11.05 million yuan from its subsidiary [23] Group 8 - Haike New Source signed a three-year supply agreement for 270,000 tons of electrolyte materials [24] - Xinhua Medical received registration certificates for several medical devices [25] - Wantai Bio received a registration certificate for an HIV antibody testing kit [26] Group 9 - Beilu Pharmaceutical obtained a drug registration certificate for a new erectile dysfunction treatment [31] - Zhongwei Company is planning to issue shares to acquire assets, leading to a stock suspension [32] - Zhejiang Haideman plans to purchase land for strategic development, with a budget of up to 260 million yuan [33] Group 10 - Ningbo Ocean announced the resignation of its deputy general manager due to job adjustments [34] - Tongguang Cable is expected to win procurement projects from the State Grid worth over 139 million yuan [35]
美邦股份:公司实际为合并报表范围内全资子公司提供的担保余额合计2.4亿元
Mei Ri Jing Ji Xin Wen· 2025-12-25 09:04
每经AI快讯,美邦股份(SH 605033,收盘价:19.7元)12月25日晚间发布公告称,截至本公告披露 日,公司对全资子公司的担保总额为7亿元,占公司2024年度经审计净资产的比例为62.24%;截至本公 告披露日,公司实际为合并报表范围内全资子公司提供的担保余额合计2.4亿元,占公司2024年度经审 计净资产的比例为21.34%。 每经头条(nbdtoutiao)——微信聊天遭老板监视,杀毒软件"失明",员工隐私被系统性采集!软件商 公开售卖"监控神器",称已服务多家企业 (记者 王晓波) 2024年1至12月份,美邦股份的营业收入构成为:农药占比99.49%,其他业务占比0.51%。 截至发稿,美邦股份市值为27亿元。 ...
美邦股份(605033) - 光大证券股份有限公司关于陕西美邦药业集团股份有限公司募投项目结项并将节余募集资金永久补充流动资金的核查意见
2025-12-25 09:01
光大证券股份有限公司 关于陕西美邦药业集团股份有限公司 摹投项目结项并将节余募集资金永久补充流动资金的 核查意见 经中国证券监督管理委员会《关于核准陕西美邦药业集团股份有限公司首 次公开发行股票的批复》(证监许可 [2021] 2738号)核准,公司向社会公开发 行人民币普通股(A 股)3,380 万股。本次公开发行人民币普通股每股面值为人 民币 1.00元,发行价格为 12.69元/股,本次发行募集资金总额为人民 428,922,000.00 元 , 扣 除 发 行 费 用 37,078,608.07 元 , 募 集 资 金 净 额 为 391.843.391.93 元。上述募集资金到位情况已经容诚会计师事务所(特殊普通合 伙) 进行了验证,并于 2021年9月 8 目出具了容诚验字[2021]第 230Z0192 号 《验资报告》。 募集资金到账后,已全部存放于经公司董事会批准开设的募集资金专项账 户内,公司与保荐人、存放募集资金的商业银行签署了《募集资金专户存储三 方监管协议》。 | 发行名称 | | 2021 年首次公开发行股份 | | --- | --- | --- | | 募集资金总 | 42,8 ...
美邦股份(605033) - 光大证券股份有限公司关于陕西美邦药业集团股份有限公司募投项目结项并将节余募集资金永久补充流动资金的核查意见
2025-12-25 09:01
光大证券股份有限公司 关于陕西美邦药业集团股份有限公司 经中国证券监督管理委员会《关于核准陕西美邦药业集团股份有限公司首 次公开发行股票的批复》(证监许可 [2021] 2738号)核准,公司向社会公开发 行人民币普通股(A 股)3,380 万股。本次公开发行人民币普通股每股面值为人 民币 1.00元,发行价格为 12.69元/股,本次发行募集资金总额为人民 428,922,000.00 元 , 扣 除 发 行 费 用 37,078,608.07 元 , 募 集 资 金 净 额 为 391.843.391.93 元。上述募集资金到位情况已经容诚会计师事务所(特殊普通合 伙) 进行了验证,并于 2021年9月 8 目出具了容诚验字[2021]第 230Z0192 号 《验资报告》。 募集资金到账后,已全部存放于经公司董事会批准开设的募集资金专项账 户内,公司与保荐人、存放募集资金的商业银行签署了《募集资金专户存储三 方监管协议》。 | 发行名称 | | 2021 年首次公开发行股份 | | --- | --- | --- | | 募集资金总 | 42,892.20 万元 | | | 额 | | | | 募集资金 ...